Theresa A. Deisher

Biography

An expert in adult stem cell research, Dr. Theresa Deisher is the first person to discover adult pluripotent stem cells. She is an inventor on over 23 issued US patents, whose discoveries have led to clinical trials of fibroblast growth factor 18 for osteoarthritis and cartilage repair, and for Factor XIII for surgical bleeding. Dr. Deisher obtained her Ph.D. in Molecular and Cellular Physiology from Stanford University Medical School and completed her post-doctoral training at the University of Washington, Hematology Division. She has 20+ years of experience in commercial biotechnology. Prior to founding AVM Biotechnology, she worked with leading biotechnology companies including Genentech, Repligen, ZymoGenetics, Immunex and Amgen. She is a frequent lecturer on stem cell issues including research, clinical progress, policy, economics and ethics. An expert in adult stem cell research, Dr. Theresa Deisher is the first person to discover adult pluripotent stem cells. She is an inventor on over 23 issued US patents, whose discoveries have led to clinical trials of fibroblast growth factor 18 for osteoarthritis and cartilage repair, and for Factor XIII for surgical bleeding. Dr. Deisher obtained her Ph.D. in Molecular and Cellular Physiology from Stanford University Medical School and completed her post-doctoral training at the University of Washington, Hematology Division. She has 20+ years of experience in commercial biotechnology. Prior to founding AVM Biotechnology, she worked with leading biotechnology companies including Genentech, Repligen, ZymoGenetics, Immunex and Amgen. She is a frequent lecturer on stem cell issues including research, clinical progress, policy, economics and ethics.

Research Interest

Pharmaceutical Sciences